Colive Voice study continues to grow » Luxembourg Institute of Health
Home » News » Colive Voice study continues to grow

News

Colive Voice study continues to grow

The Quebec Cancer Foundation helps advance the identification of vocal biomarkers for cancer

28 March 2022 5minutes

Support for Colive Voice, a digital health study led by the Department of Precision Health’s (DoPH) Deep Digital Phenotyping research unit, is crossing the Atlantic. The project is an international initiative that aims to identify vocal biomarkers – characteristics of the voice that can be associated with a given health condition – in order to advance the diagnosis, risk prediction and remote monitoring of various chronic diseases (cancer, diabetes, covid-19, inflammatory bowel diseases, mental health disorders…). The Quebec Cancer Foundation will support the recruitment of participants in Quebec by giving visibility to this project.

Colive Voice study continues to grow The Quebec Cancer Foundation helps advance the identification of vocal biomarkers for cancer Support for Colive Voice, a digital health study led by the Department of Precision Health’s (DoPH) Deep Digital Phenotyping research unit, is crossing the Atlantic. The project is an international initiative that aims to identify vocal […]

The Quebec Cancer Foundation is deeply involved with people living with cancer and their loved ones, offering services that focus on their needs and help simplify their daily lives. The Foundation supports people with cancer throughout their journey, from diagnosis to treatment, and implements actions to raise awareness of this serious disease in the workplace.

Simultaneously, the Quebec Cancer Foundation provides the Info-cancer Hotline, which makes it possible to easily consult oncology professionals with confidentiality and free of charge, by one phone call. It also offers very concrete services to support patients on a daily basis: accommodation so that patients can receive their treatments even far from home or if they are too tired to travel, psychological support, physical well-being programs (kinesiology, massage therapy, etc.), and a corporate support program.

The new participants recruited thanks to the Quebec Cancer Foundation gives Colive Voice researchers hope to make progress in identifying vocal biomarkers related to different cancer types. In a few years, the detected vocal biomarkers will make it possible to improve remote monitoring of frequently reported cancer symptoms, such as pain, fatigue, stress or anxiety. They will also improve remote monitoring of patients through the integration of voice based monitoring in telemedicine solutions or through a mobile application accessible on a smartphone. The identified vocal biomarkers could, one day, provide new diagnostic tools to promote early detection of cancers, a key factor in improving survival rates.

The Quebec Cancer Foundation and Colive Voice researchers are working together to achieve a common goal: to simplify the daily lives of patients during and after their treatment. The implementation of voice monitoring will significantly improve the well-being and quality of life of cancer patients, which aligns with the approach proposed by the Foundation for several years already.

The support of the Quebec Cancer Foundation is essential for the international recruitment of Colive Voice participants.The visibility provided will allow us to recruit enough participants with diverse backgrounds, to progress on identifying key voice biomarkers that will in turn help us make a meaningful difference in the lives of cancer patients. We are extremely grateful for their collaboration.

said Dr. Guy Fagherazzi, Director of the Precision Health Department and principal investigator of Colive Voice.

About the Quebec Cancer Foundation (QCF)

For more than 40 years, the Quebec Cancer Foundation has used the funds raised to provide daily support to thousands of Quebecers living with cancer and their loved ones. It offers physical well-being programs and psychological support through its Regional Centers in Montreal, Quebec City, Sherbrooke, Gatineau, Trois-Rivières and Lévis, in addition to having the largest network of accommodations in the province. It also offers adapted assistance to young people aged 15 to 39 affected by cancer through its Programme à Félix. Finally, through its Info-cancer Services, the Foundation offers support, answers and comfort throughout Quebec.

cancerquebec.com

About Colive Voice Project

Colive Voice is an international digital health research initiative that aims to improve diagnosis and monitoring of various chronic conditions (like diabetes, cancer, COVID-19) by evaluating voice features known as vocal biomarkers. This innovative study is led by the Deep Digital Phenotyping (DDP), a research unit of the Luxembourg Institute of Health. Participation is open to all adults and adolescents above 15 years of age regardless of their health status, and is done anonymously via a secure web application. Colive Voice is accessible from a smartphone, tablet, or laptop equipped with a microphone.

To participate, or for more information, visit

https://www.colivevoice.org

About the luxembourg institute of health

The Luxembourg Institute of Health (LIH) is a public biomedical research organization focused on precision health and invested in becoming a leading reference in Europe for the translation of scientific excellence into meaningful benefits for patients.

LIH places the patient at the heart of all its activities, driven by a collective obligation towards society to use knowledge and technology arising from research on patient derived data to have a direct impact on people’s health. Its dedicated teams of multidisciplinary researchers strive for excellence, generating relevant knowledge linked to immune related diseases and cancer.

The institute embraces collaborations, disruptive technology and process innovation as unique opportunities to improve the application of diagnostics and therapeutics with the long-term goal of preventing disease.

www.lih.lu


Scientific Contact

  • Guy
    Fagherazzi
    PhD, Director of Department, Research Group Leader
Share

Related News